Montreal-based Hexavest bought 1.7 million more shares of GE. It also bought Chipotle and Exxon.
Global growth and rising profits should keep the bull market humming. But keep an eye on interest rates.
It’s easy to hate the Faang stocks. It’ll be harder to make them go away.
Like thieves who create a distraction to mask their crime, the bond market’s brief selloff last week drew attention away from what might be the real issue: U.S. trade relations.
Drawing a net $73 billion, they topped all actively managed mutual funds.
For stock investors, the direction of interest rates seems to matter less than the point where we stand in the cycle.
TIAA-CREF Large-Cap Growth’s Susan Hirsch has been staying on top of technology changes for more than 40 years.
Stocks have started the year with a nearly uninterrupted run—one that has us imagining just how high the market can go.
In a growth-happy year, our value recommendations didn’t keep pace, but short ideas did very well.
The smartphone-chip maker invades Broadcom’s back yard, and makes the point that it still has the moxie to compete on its own
Activist investor Jana Partners’ push to get Apple to consider the impact of iPhone use on children represents a new front for seeking changes.
OPEC’s production limits and rising demand should push prices still higher.
The Osaka-based company is reaping big profits from factory automation sensors, artificial intelligence, and 3-D vision systems. Stock’s upside: 40%.
Not as famous as its rivals, Next has beaten expectations, including its own, during the holiday season. One reason: its web operation.
Investors may be rattled, but falling prices probably won’t stop them from buying new Treasuries.
Buying on the dips might keep working for a while. When it doesn’t, locking in gains and protecting against a rout will be important.
Six pharma/biotech stocks that should provide good yields in 2018.
The asset manager has been struggling with investment outflows. But the new tax law and prospect of a chunk of $10 billion in cash going to shareholders is a reason to buy the stock.
Cryptocurrencies took a hit after South Korea and China moved to quell speculation. In the U.S., bitcoin ETFs waited for the SEC.